Cellectar Biosciences (CLRB) Stock Chart & Stock Price History $4.88 +0.39 (+8.69%) Closing price 04:00 PM EasternExtended Trading$4.88 0.00 (-0.10%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectar Biosciences Stock Price Performance The Cellectar Biosciences (CLRB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 92.24%, with a year-to-date return of -45.76%. In the past month, the stock has decreased 6.44%, reflecting recent market activity. As of the latest close, Cellectar Biosciences traded at $4.49 with a market cap of $8.13 million and volume of 90,700 shares. Five years ago, the stock traded at a split-adjusted price of $354.00, representing a 98.63% decrease over that period. At the time, it had a market cap of $34.62 million and a volume of 16,787 shares. Receive CLRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.10%1 Month Performance-6.44%3 Month Performance-35.65%Year-To-Date Performance-45.76%1 Year Performance-92.24%5 Year Performance-98.63% CLRB Stock Chart for Friday, August, 22, 2025 CLRB Chart by TradingView Cellectar Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$4.41$4.49+1.81%$4.68$4.2290,700 shs$8.13 million08/20/2025$4.50$4.41-2.00%$4.55$4.11134,889 shs$7.98 million08/19/2025$4.70$4.50-4.26%$4.73$4.5080,860 shs$8.15 million08/18/2025$4.34$4.70+8.29%$4.92$4.40386,813 shs$8.51 million08/15/2025$4.42$4.34-1.81%$4.72$4.23321,846 shs$7.86 million08/14/2025$4.42$4.42$4.94$4.31738,736 shs$8 million08/13/2025$4.61$4.42-4.12%$4.68$4.38122,155 shs$8 million08/12/2025$4.44$4.61+3.83%$4.62$4.4431,690 shs$8.34 million08/11/2025$4.73$4.44-6.13%$4.72$4.3988,104 shs$8.04 million08/08/2025$4.71$4.73+0.42%$4.84$4.5871,330 shs$8.56 million Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$4.78$4.71-1.46%$4.96$4.7065,825 shs$8.53 million08/06/2025$4.87$4.78-1.85%$4.99$4.7539,194 shs$8.65 million08/05/2025$5.06$4.87-3.75%$5.01$4.7241,186 shs$8.82 million08/04/2025$4.72$5.06+7.20%$5.09$4.77145,884 shs$9.16 million08/01/2025$4.84$4.72-2.48%$4.92$4.4484,512 shs$8.54 million07/31/2025$4.78$4.84+1.26%$5.15$4.80111,238 shs$8.76 million07/30/2025$4.71$4.78+1.49%$5.09$4.69128,336 shs$8.65 million07/29/2025$5.03$4.71-6.36%$5.11$4.65126,705 shs$8.53 million07/28/2025$5.09$5.03-1.18%$5.38$4.94135,458 shs$9.10 million07/25/2025$5.35$5.09-4.86%$5.44$5.0595,926 shs$9.21 million07/24/2025$5.59$5.35-4.29%$5.61$5.21164,734 shs$9.68 million07/23/2025$5.20$5.59+7.50%$5.85$5.19382,802 shs$10.12 million07/22/2025$5.23$5.20-0.57%$5.45$5.15100,607 shs$9.41 million07/21/2025$4.99$5.23+4.81%$5.45$5.09130,613 shs$9.47 million Related Companies MURA Stock Price Chart MAAQ Stock Price Chart CASI Stock Price Chart TRIB Stock Price Chart KZR Stock Price Chart JATT Stock Price Chart MIRA Stock Price Chart RNTX Stock Price Chart TENX Stock Price Chart DYAI Stock Price Chart Receive CLRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLRB) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access